InvestorsHub Logo
Followers 56
Posts 8436
Boards Moderated 0
Alias Born 05/14/2015

Re: 29YEARINVESTOR post# 116091

Friday, 12/16/2022 9:08:01 AM

Friday, December 16, 2022 9:08:01 AM

Post# of 118383
For all the misinformation about the bogus naked shorting being spouted, there is one key fact that disputes that naked shorting is an issue for RGBP.

The fact that good ol David Rectum Koos has NEVER EVER mentioned it being an issue in affecting the stock.

Why is that?

BECAUSE IT ISN'T AN ISSUE.

Don't you think that the business leader Koos, as other competent CEOs have in the past done, would have brought up this issue as affecting the pps if he thought it was happening to the level that we are being told it is?

OF course he would! But it isn't because the baseless posts about naked shorting is just they typical misinformation to try and explain away the real reason why the pps is where it is. And it's all about lack of execution, dilution, and no business prospects for REGEN. Everything Koos touches turns to crap.

Where is oncofakeapharma?
Where is that CSO?
Where is that CFO?
Where is that Lilly deal?
Where is Kesari?
Where is the reactivation of the INDs with the FDA?
Where is Hemaxellerate trials?
Where is the funding?

The naked shorting canard is misinformation and the true traders know this.
Bearish
Bearish

FACTS are stubborn things